US Selumetinib Registry

clipboard-pencil

About the study

The purpose of this study is to understand treatment patterns and assess long-term effectiveness and safety outcomes associated with selumetinib treatment as well as to explore clinical and non-clinical factors affecting those outcomes in patients with neurofibromatosis type 1 (NF1) and plexiform neurofibromas (PNs) who started selumetinib between the ages of 2 to 18 years inclusive, and initiated selumetinib treatment on or after 10 April 2020 in a real-world setting.
user-3

Who can take part

You may be eligible to participate in the study if you meet the following criteria:

INCLUSION CRITERIA

Inclusion Criteria:


  1. Participants diagnosed with NF1 and PN
  2. Started selumetinib between the ages of 2 to 18 years inclusive, and initiated selumetinib treatment on or after 10 April 2020, including patients who:
  3. Discontinued selumetinib before enrollment; or
  4. Initiated treatment before enrollment and are currently on selumetinib; or
  5. Initiated selumetinib on the day of enrollment or intend to initiate selumetinib within 3 months after enrollment
  6. Able to give written informed consent. Participant or participant's parent/legal guardian must be willing and able to give written informed consent and the participant (if minor) must be willing to give written informed assent.

EXCLUSION CRITERIA

Exclusion Criteria:


* Participants currently participating in any clinical trials at time of enrollment or initiation of selumetinib.


pin location

Study Locations

Enter your ZIP code/Postal code/PIN code to locate study sites near you:

How to Apply


Contact the study center to learn if this study is a good match for you.
Phone iconCall 1-855-752-2356Email iconEmail Study Center

Study Details


Contition
Neurofibromatosis Type 1,Plexiform Neurofibromas
Age
2 - 22
Participants Needed
200
Est. Completion Date
Jun 21, 2028
Treatment Type
OBSERVATIONAL

Sponsor
Alexion Pharmaceuticals, Inc.
ClinicalTrials.gov NCT Identifier
NCT05683678
Study Number
ALX-NF1-501

Understanding Clinical Trials


Get answers to your questions about clinical trials.What is clinical research?What does taking part in clinical trials involve?What should I ask the trial doctor?
Vector

Interested?

Sign up to create a personal profile and 
receive news, resources, and alerts 
about clinical trials related to your conditions of interest.